![Mikael Søndergaard Thomsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mikael Søndergaard Thomsen
Fondateur chez
INITIATOR PHARMA A/S
Profil
Mikael Søndergaard Thomsen was the founder of Bridge Bioresearch Plc, founded in 2010, serving as Chief Scientific Officer from 2010 to 2012.
Dr. Thomsen was the founder of Contera Pharma A, founded in 2010, serving as Chief Scientific Officer from 2010 to 2014.
Dr. Thomsen is the founder of Conrig Pharma ApS, founded in 2010, serving as Director & Chief Scientific Officer since 2012.
Dr. Thomsen is the founder of Initiator Pharma A, founded in 2016, serving as Chief Development Officer.
Dr. Thomsen is also the founder of Sound Biotechnology, Inc.,Oxford UK Ltd,Prosidion Ltd...
Dr. Thomsen worked as Principal at Novartis Pharma Schweiz AG, US Food & Drug Administration, and Novo Nordisk, Inc. Dr. Thomsen worked as Chief Development Officer at Vivoryon Therapeutics NV.
Dr. Thomsen completed undergraduate studies at the University of Basel and graduate and doctorate degrees at the University of Copenhagen.
Postes actifs de Mikael Søndergaard Thomsen
| Sociétés | Poste | Début |
|---|---|---|
| INITIATOR PHARMA A/S | Fondateur | 01/01/2016 |
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Provides drug for oral treatment of atopical disease | Fondateur | 20/12/2010 |
Anciens postes connus de Mikael Søndergaard Thomsen
| Sociétés | Poste | Fin |
|---|---|---|
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of patients | Fondateur | 01/01/2014 |
Bridge Bioresearch Plc
 Bridge Bioresearch Plc Medical/Nursing ServicesHealth Services Develops drug for obesity and metabolic disorders | Fondateur | 31/03/2011 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
| VIVORYON THERAPEUTICS N.V. | Corporate Officer/Principal | - |
Sound Biotechnology, Inc. | Fondateur | - |
Formation de Mikael Søndergaard Thomsen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Oxford UK Ltd
 Oxford UK Ltd Financial ConglomeratesFinance Oxford UK Ltd is a private company based in Brighouse, UK. and has subsidiaries in the United Kingdom. The British company was founded by Mikael Søndergaard Thomsen. | Finance |
Prosidion Ltd.
 Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Bridge Bioresearch Plc
Bridge Bioresearch Plc Medical/Nursing ServicesHealth Services Develops drug for obesity and metabolic disorders | Health Services |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Contera Pharma ApS
Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of patients | Health Technology |
Sound Biotechnology, Inc. | |
Conrig Pharma ApS
Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Provides drug for oral treatment of atopical disease | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
